Barclays PLC Bridge Bio Pharma, Inc. Transaction History

Barclays PLC

$353 Billion
Q1 2025

A detailed history of Barclays PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Barclays PLC holds 388,838 shares of BBIO stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

388,838

Previous 447,510 13.11%

Holding current value

$18 Million

Previous $12.3 Million 9.46%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$28.12 - $37.59 $1.65 Million - $2.21 Million	-58,672 Reduced 13.11%	388,838 $13.4 Million
Q4 2024 Feb 13, 2025	SELL	$22.35 - $29.5 $2.18 Million - $2.88 Million	-97,498 Reduced 17.89%	447,510 $12.3 Million
Q3 2024 Nov 15, 2024	BUY	$23.91 - $31.3 $3.15 Million - $4.12 Million	131,743 Added 31.88%	545,008 $13.9 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $186,231 - $251,330	8,097 Added 2.0%	413,265 $10.5 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $9.21 Million - $13.6 Million	-336,870 Reduced 45.4%	405,168 $12.5 Million
Q4 2023 Feb 15, 2024	BUY	$24.02 - $43.89 $6.26 Million - $11.4 Million	260,598 Added 54.13%	742,038 $30 Million
Q3 2023 Nov 07, 2023	SELL	$16.89 - $35.01 $1.82 Million - $3.77 Million	-107,724 Reduced 18.28%	481,440 $12.7 Million
Q2 2023 Aug 03, 2023	SELL	$13.29 - $18.01 $1.09 Million - $1.47 Million	-81,715 Reduced 12.18%	589,164 $10.1 Million
Q1 2023 May 04, 2023	SELL	$7.17 - $18.55 $3.81 Million - $9.85 Million	-531,006 Reduced 44.18%	670,879 $11.1 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $5.9 Million - $10.1 Million	875,468 Added 268.21%	1,201,885 $9.16 Million
Q3 2022 Nov 03, 2022	BUY	$7.94 - $12.36 $2.36 Million - $3.67 Million	296,979 Added 1008.83%	326,417 $3.24 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $68,501 - $159,616	-13,148 Reduced 30.87%	29,438 $268,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $1.11 Million - $2.6 Million	-151,488 Reduced 78.06%	42,586 $432,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $1.19 Million - $5.58 Million	104,508 Added 116.68%	194,074 $3.24 Million
Q3 2021 Nov 09, 2021	BUY	$46.87 - $64.24 $1.24 Million - $1.71 Million	26,546 Added 42.12%	89,566 $4.2 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $1.73 Million - $2.38 Million	-37,199 Reduced 37.12%	63,020 $3.84 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $3.54 Million - $4.61 Million	63,771 Added 174.96%	100,219 $6.17 Million
Q4 2020 Feb 11, 2021	BUY	$38.38 - $71.11 $118,056 - $218,734	3,076 Added 9.22%	36,448 $2.59 Million
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $329,555 - $511,174	-12,116 Reduced 26.64%	33,372 $1.25 Million
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $358,275 - $575,465	16,124 Added 54.91%	45,488 $1.48 Million
Q1 2020 May 13, 2020	BUY	$16.11 - $36.23 $52,035 - $117,022	3,230 Added 12.36%	29,364 $851,000
Q4 2019 Feb 10, 2020	BUY	$17.96 - $46.63 $223,260 - $579,657	12,431 Added 90.72%	26,134 $916,000
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $73,092 - $117,571	-3,631 Reduced 20.95%	13,703 $294,000
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $467,497 - $477,551	17,334 New	17,334 $467,000

Others Institutions Holding BBIO

# of Institutions

372

Shares Held

184M

Call Options Held

12.8M

Put Options Held

2.28M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $6.87B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account